110 related articles for article (PubMed ID: 35216969)
21. microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression.
Maity S; Bera A; Ghosh-Choudhury N; Das F; Kasinath BS; Choudhury GG
Exp Cell Res; 2018 Mar; 364(1):5-15. PubMed ID: 29397070
[TBL] [Abstract][Full Text] [Related]
22. Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells.
Catena V; Bruno T; De Nicola F; Goeman F; Pallocca M; Iezzi S; Sorino C; Cigliana G; Floridi A; Blandino G; Fanciulli M
Oncotarget; 2016 Oct; 7(43):70546-70558. PubMed ID: 27655709
[TBL] [Abstract][Full Text] [Related]
23. DEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity.
Cui D; Dai X; Gong L; Chen X; Wang L; Xiong X; Zhao Y
Cell Death Dis; 2020 Nov; 11(11):976. PubMed ID: 33184290
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells.
Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S
Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084
[TBL] [Abstract][Full Text] [Related]
25. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation.
Parrales A; López E; Lee-Rivera I; López-Colomé AM
Cell Signal; 2013 Apr; 25(4):829-38. PubMed ID: 23291002
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between PI3 kinase/PDK1/Akt/Rac1 and Ras/Raf/MEK/ERK pathways downstream PDGF receptor.
Niba ET; Nagaya H; Kanno T; Tsuchiya A; Gotoh A; Tabata C; Kuribayashi K; Nakano T; Nishizaki T
Cell Physiol Biochem; 2013; 31(6):905-13. PubMed ID: 23817184
[TBL] [Abstract][Full Text] [Related]
27. Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways.
Yue L; Haroun S; Parent JL; de Brum-Fernandes AJ
Bone; 2014 Mar; 60():112-21. PubMed ID: 24345643
[TBL] [Abstract][Full Text] [Related]
28. DEPTOR expression negatively correlates with mTORC1 activity and tumor progression in colorectal cancer.
Lai EY; Chen ZG; Zhou X; Fan XR; Wang H; Lai PL; Su YC; Zhang BY; Bai XC; Li YF
Asian Pac J Cancer Prev; 2014; 15(11):4589-94. PubMed ID: 24969890
[TBL] [Abstract][Full Text] [Related]
29. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6.
Shi Y; Hsu JH; Hu L; Gera J; Lichtenstein A
J Biol Chem; 2002 May; 277(18):15712-20. PubMed ID: 11872747
[TBL] [Abstract][Full Text] [Related]
30. DEPTOR-mTOR Signaling Is Critical for Lipid Metabolism and Inflammation Homeostasis of Lymphocytes in Human PBMC Culture.
Xie QB; Liang Y; Yang M; Yang Y; Cen XM; Yin G
J Immunol Res; 2017; 2017():5252840. PubMed ID: 28349073
[TBL] [Abstract][Full Text] [Related]
31. DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells.
Obara A; Fujita Y; Abudukadier A; Fukushima T; Oguri Y; Ogura M; Harashima S; Hosokawa M; Inagaki N
Biochem Biophys Res Commun; 2015 May; 460(4):1047-52. PubMed ID: 25843797
[TBL] [Abstract][Full Text] [Related]
32. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
[TBL] [Abstract][Full Text] [Related]
33. Downstream effectors of oncogenic ras in multiple myeloma cells.
Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR.
Liu M; Wilk SA; Wang A; Zhou L; Wang RH; Ogawa W; Deng C; Dong LQ; Liu F
J Biol Chem; 2010 Nov; 285(47):36387-94. PubMed ID: 20851890
[TBL] [Abstract][Full Text] [Related]
35. Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma.
Cirstea D; Hideshima T; Rodig S; Santo L; Pozzi S; Vallet S; Ikeda H; Perrone G; Gorgun G; Patel K; Desai N; Sportelli P; Kapoor S; Vali S; Mukherjee S; Munshi NC; Anderson KC; Raje N
Mol Cancer Ther; 2010 Apr; 9(4):963-75. PubMed ID: 20371718
[TBL] [Abstract][Full Text] [Related]
36. Dynamic balancing: DEPTOR tips the scales.
Proud CG
J Mol Cell Biol; 2009 Dec; 1(2):61-3. PubMed ID: 19706736
[TBL] [Abstract][Full Text] [Related]
37. Androgen receptor functions as a negative transcriptional regulator of DEPTOR, mTOR inhibitor.
Kanno Y; Zhao S; Yamashita N; Yanai K; Nemoto K; Inouye Y
J Toxicol Sci; 2015 Dec; 40(6):753-8. PubMed ID: 26558456
[TBL] [Abstract][Full Text] [Related]
38. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
Shi Y; Gera J; Hu L; Hsu JH; Bookstein R; Li W; Lichtenstein A
Cancer Res; 2002 Sep; 62(17):5027-34. PubMed ID: 12208757
[TBL] [Abstract][Full Text] [Related]
39. In human endothelial cells amino acids inhibit insulin-induced Akt and ERK1/2 phosphorylation by an mTOR-dependent mechanism.
Pellegatta F; Catapano AL; Luzi L; Terruzzi I
J Cardiovasc Pharmacol; 2006 May; 47(5):643-9. PubMed ID: 16775502
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells.
Liu S; Ma Z; Cai H; Li Q; Rong W; Kawano M
Eur J Haematol; 2010 Feb; 84(2):137-44. PubMed ID: 19878271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
